What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Learn how to weight dividend ETFs by income versus growth to tailor risk, cash flow, and long-term growth in your retirement portfolio.
23,884 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Bahrain unfolds a nimble, regulation-forward investment strategy designed to stand out as Gulf markets compete for ca...
Morgan Stanley reveals a sharper cost curve for AI data centers, suggesting only a few players can fund the next wave...
As the AI boom strong powers data-center growth, memory stocks are slipping. Analysts point to cyclical supply dynami...
Aaron Kirman is expanding beyond brokerage into AI-driven underwriting, crypto-backed loans and new development finan...
Three women chop their way into the record books at the Lumberjack World Championships in Hayward, WI, as new marks p...
Two tech giants are racing to power AI at scale, pouring hundreds of billions into data centers and power. The big qu...
A delayed earnings release and a premium acquisition sparked a slide in Valaris shares. This article breaks down what...
OpenAI is nearing a private funding round that could push its valuation above $850 billion, a level that would outstr...
Goldman Sachs updated its governance policy to remove formal DEI criteria from director selection, aligning with peer...
A noted market analyst warns that Strategy’s aggressive Bitcoin purchases echo dot-com-era speculation, risking a ste...
Private builders face heightened competition from public homebuilders in 2026. A new IBS session maps a practical pri...